4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001628280-25-035269
EVP and Chief Medical Officer sold 10,382 shares at an average $5.47 ($56,791)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Eisner Mark EVP and Chief Medical Officer | 2025-07-15 | Sale 10b5-1 | −6,796 | $5.47 | $37,162 | 108,204 | D |
| Eisner Mark EVP and Chief Medical Officer | 2025-07-17 | Sale 10b5-1 | −3,586 | $5.47 | $19,629 | 104,618 | D |
| Open-market sales · 10,382 sh · avg $5.47 · $56,791 | |||||||
Loading xslF345X05/wk-form4_1752792412.xml…